Sutro Biopharma Inc

STRO

Company Profile

  • Business description

    Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

  • Contact

    111 Oyster Point Boulevard
    South San FranciscoCA94080
    USA

    T: +1 650 881-6500

    https://www.sutrobio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    244

Stocks News & Analysis

stocks

Undervalued ASX share with plan to mitigate tariff risk

Shares have dropped 20% in the previous year due to concerns about tariffs.
stocks

Earnings up but shares overvalued for ASX gold miner

Higher gold prices are making a difference to the bottom line but investors overly optimistic.
stocks

Alphabet: Anthropic deal and Gemini momentum stand to deliver; Fair Value up 27%

We see faster cloud growth and improved longer-term profitability for Alphabet.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,295.8026.20-0.28%
CAC 408,219.6219.56-0.24%
DAX 4024,248.8559.93-0.25%
Dow JONES (US)47,544.59337.470.71%
FTSE 1009,654.070.250.00%
HKSE26,346.1487.56-0.33%
NASDAQ23,637.46432.591.86%
Nikkei 22550,219.18293.14-0.58%
NZX 50 Index13,402.6611.070.08%
S&P 5006,875.1683.471.23%
S&P/ASX 2009,012.5016.30-0.18%
SSE Composite Index3,988.228.72-0.22%

Market Movers